Posts

Posted on

THOR Industries Announces Date For Its Fiscal First Quarter Of 2021 Earnings Release

PR Newswire

ELKHART, Ind., Nov. 23, 2020 /PRNewswire/ — THOR Industries, Inc. (NYSE: THO) today announced that the date for its fiscal first quarter earnings release will be on Tuesday, December 8, 2020, before the market opens.

Upon the release of THOR’s earnings, the Company will concurrently provide a comprehensive question and answer document and a slide presentation on the Company’s website. To view prior quarter earnings documents, go to http://ir.thorindustries.com/.

About THOR Industries, Inc.
THOR is the sole owner of operating subsidiaries that, combined, represent the world’s largest manufacturer of recreational vehicles. For more information on the Company and its products, please go to www.thorindustries.com.

Forward Looking Statements
This release includes certain statements that are “forward-looking” statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are made based on management’s current expectations and beliefs regarding future and anticipated developments and their effects upon THOR, and inherently involve uncertainties and risks. These forward-looking statements are not a guarantee of future performance. We cannot assure you that actual results will not differ materially from our expectations. Factors which could cause materially different results include, among others: the extent and impact from the continuation of the coronavirus pandemic, along with the responses to contain the spread of the virus by various governmental entities or other actors, which may have negative effects on retail customer demand, our independent dealers, our supply chain, or our production and which may have a negative impact on our consolidated results of operations, financial position, cash flows and liquidity; the ability to ramp production up or down quickly in response to rapid changes in demand while also managing costs and market share; the effect of raw material and commodity price fluctuations, and/or raw material, commodity or chassis supply restrictions; the impact of tariffs on material or other input costs; the level and magnitude of warranty claims incurred; legislative, regulatory and tax law and/or policy developments including their potential impact on our dealers and their retail customers or on our suppliers; the costs of compliance with governmental regulation; legal and compliance issues including those that may arise in conjunction with recently completed transactions; lower consumer confidence and the level of discretionary consumer spending; interest rate fluctuations and their potential impact on the general economy and specifically on our dealers and consumers; the impact of exchange rate fluctuations; restrictive lending practices which could negatively impact our independent dealers and/or retail consumers; management changes; the success of new and existing products and services; the ability to efficiently utilize existing production facilities; changes in consumer preferences; the risks associated with acquisitions, including: the pace and successful closing of an acquisition, the integration and financial impact thereof, the level of achievement of anticipated operating synergies from acquisitions, the potential for unknown or understated liabilities related to acquisitions, the potential loss of existing customers of acquisitions, and our ability to retain key management personnel of acquired companies; a shortage of necessary personnel for production and increasing labor costs to attract production personnel in times of high demand; the loss or reduction of sales to key dealers; disruption of the delivery of units to dealers; increasing costs for freight and transportation; asset impairment charges; cost structure changes; competition; the impact of potential losses under repurchase or financed receivable agreements; the potential impact of the strength of the U.S. dollar on international demand for products priced in U.S. dollars; general economic, market and political conditions in the various countries in which our products are produced and/or sold; the impact of changing emissions and other regulatory standards in the various jurisdictions in which our products are produced and/or sold; changes to our investment and capital allocation strategies or other facets of our strategic plan; and changes in market liquidity conditions, credit ratings and other factors that may impact our access to future funding and the cost of debt. These and other risks and uncertainties are discussed more fully in Item 1A of our Annual Report on Form 10-K for the year ended July 31, 2020.

We disclaim any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this release or to reflect any change in our expectations after the date hereof or any change in events, conditions or circumstances on which any statement is based, except as required by law.

Contact

Mark Trinske

Vice President of Investor Relations
(574) 970-7912
[email protected]

 

 

Cision View original content:http://www.prnewswire.com/news-releases/thor-industries-announces-date-for-its-fiscal-first-quarter-of-2021-earnings-release-301178324.html

SOURCE Thor Industries, Inc.

Posted on

NICE Actimize Announces Next-Gen Fraud Management Platform Leveraging Advanced AI and the Cloud to Fight Fraud and Enhance Customer Experience

NICE Actimize Announces Next-Gen Fraud Management Platform Leveraging Advanced AI and the Cloud to Fight Fraud and Enhance Customer Experience

With end-to-end operational enhancements, the latest release of IFM-X continually adapts to ever-changing customer behaviors and criminal threats to reduce fraud

HOBOKEN, N.J.–(BUSINESS WIRE)–NICE Actimize, a NICE business (Nasdaq: NICE), today announced the latest version of its Integrated Fraud Management (IFM-X) platform that delivers one of the industry’s most advanced detection capabilities powered by artificial intelligence and machine learning. Providing a real-time response in detection and decisioning across some of the most extensive fraud coverage available on the market, NICE Actimize’s IFM-X introduces new capabilities that support financial services firms’ digital acceleration strategies with fraud management solutions for digital, real-time and open banking channels.

By utilizing NICE Actimize’s advanced IFM-X platform, financial institutions will achieve best-in-class fraud detection, prevention and end-to-end operational improvements. IFM-X offers enhanced, accelerated data acquisition capabilities which enable financial institutions to leverage the vast amount of identity, device and other critical data elements required for advanced enterprise fraud management.

This next-generation fraud management (EFM) platform enables holistic, cross-channel fraud management that is flexible and scalable. IFM-X is driven by advanced “Always on AI” and built upon deep industry expertise to provide clients with the ability to address new and emerging fraud trends with constantly adapting models that stop new fraud threats in their tracks. The advanced capabilities of IFM-X are able to power the entire suite of NICE Actimize Enterprise Fraud solutions, covering multiple payments products and servicing channels to allow organizations to stop fraud while delivering exceptional customer experiences.

“Financial services organizations require advanced data capabilities and automation to support their journey of digitalization to stay competitive and provide optimal customer experiences,” said Craig Costigan, CEO, NICE Actimize. “New market factors are influencing financial institutions’ strategies, including their reliance on specialized fraud solutions which enable scalable fraud coverage across an increasingly complex environment. The AI-driven IFM-X platform is designed to address these evolving needs.”

The updated NICE Actimize IFM-X platform includes the following enhanced features and benefits:

  • Open, always-on and agile analytics –powered by the X-Sight AI cloud, IFM-X provides best-in-class data intelligence, analytics and insights on a single cloud-native platform. Adaptable analytics offer more accurate real-time fraud detection, continuous feature engineering using Federated Learning techniques that leverage NICE Actimize’s proprietary payment fraud consortium and integrated modeling tools for self-development and support for Bring Your Own (BYO) Analytics. Quick production deployment of containerized models enables the agility FI’s need to adapt to the changing fraud landscape.
  • Easy data integration –Marking its continued investment in advanced data capabilities, IFM-X consumes from scalable, real-time data streams, interdicts and informs downstream systems with fraud intelligence in real-time.
  • Unprecedented performance and scalability – IFM-X enables organizations to consolidate cross-channel fraud management while maintaining the rapid detection required for real-time environments.
  • Entity-driven fraud investigation and resolution – Entity-centric triage and investigations provide a single, comprehensive view of customer intelligence for better, faster decisions which reduces resolution time and cost for fraud operation teams.

For additional information on NICE Actimize’s IFM-X platform, please clickhere.

About NICE Actimize

NICE Actimize is the largest and broadest provider of financial crime, risk and compliance solutions for regional and global financial institutions, as well as government regulators. Consistently ranked as number one in the space, NICE Actimize experts apply innovative technology to protect institutions and safeguard consumers and investors assets by identifying financial crime, preventing fraud and providing regulatory compliance. The company provides real-time, cross-channel fraud prevention, anti-money laundering detection, and trading surveillance solutions that address such concerns as payment fraud, cybercrime, sanctions monitoring, market abuse, customer due diligence and insider trading. Find us at www.niceactimize.com, @NICE_Actimize or Nasdaq: NICE.

About NICE

NICE (Nasdaq: NICE) is the world’s leading provider of both cloud and on-premises enterprise software solutions that empower organizations to make smarter decisions based on advanced analytics of structured and unstructured data. NICE helps organizations of all sizes deliver better customer service, ensure compliance, combat fraud and safeguard citizens. Over 25,000 organizations in more than 150 countries, including over 85 of the Fortune 100 companies, are using NICE solutions. www.nice.com.

Trademark Note: NICE and the NICE logo are trademarks or registered trademarks of NICE Ltd. All other marks are trademarks of their respective owners. For a full list of NICE’s marks, please see: www.nice.com/nice-trademarks.

Forward-Looking Statements

This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements, including the statements by Mr. Costigan, are based on the current beliefs, expectations and assumptions of the management of NICE Ltd. (the “Company”). In some cases, such forward-looking statements can be identified by terms such as “believe,” “expect,” “seek,” “may,” “will,” “intend,” “should,” “project,” “anticipate,” “plan,” “estimate,” or similar words. Forward-looking statements are subject to a number of risks and uncertainties that could cause the actual results or performance of the Company to differ materially from those described herein, including but not limited to the impact of changes in economic and business conditions, including as a result of the COVID-19 pandemic; competition; successful execution of the Company’s growth strategy; success and growth of the Company’s cloud Software-as-a-Service business; changes in technology and market requirements; decline in demand for the Company’s products; inability to timely develop and introduce new technologies, products and applications; difficulties or delays in absorbing and integrating acquired operations, products, technologies and personnel; loss of market share; an inability to maintain certain marketing and distribution arrangements; the Company’s dependency on third-party cloud computing platform providers, hosting facilities and service partners;, cyber security attacks or other security breaches against the Company; the effect of newly enacted or modified laws, regulation or standards on the Company and our products and various other factors and uncertainties discussed in our filings with the U.S. Securities and Exchange Commission (the “SEC”). For a more detailed description of the risk factors and uncertainties affecting the company, refer to the Company’s reports filed from time to time with the SEC, including the Company’s Annual Report on Form 20-F. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company undertakes no obligation to update or revise them, except as required by law.

Corporate Media Contact:

Cindy Morgan-Olson, +1 646 408 5896, NICE Actimize, [email protected], ET

Investors:

Marty Cohen, +1 551 256 5354, ET, [email protected]

Yisca Erez, +972 9 775 3798, CET, [email protected]

KEYWORDS: New Jersey United States North America

INDUSTRY KEYWORDS: Software Internet Finance Banking Data Management Professional Services Technology Security

MEDIA:

Logo
Logo
Posted on

Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb

Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb

Schrödinger to receive $55 million upfront; eligible to receive up to $2.7 billion in milestone payments plus royalties

NEW YORK–(BUSINESS WIRE)–
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced a discovery collaboration with Bristol Myers Squibb Company (NYSE: BMY) to discover, develop, and commercialize therapeutics in multiple disease areas.

The multi-year collaboration will combine Schrödinger’s leading physics-based computational platform and drug discovery capabilities with Bristol Myers Squibb’s expertise in development and commercialization to advance small molecule therapeutics for targets in oncology, immunology, and neurological disorders. The collaboration includes two of Schrödinger’s early-stage programs and additional undisclosed targets. Schrödinger will be responsible for the discovery of development candidates for each of the targets under the collaboration. Bristol Myers Squibb will then be responsible for the development, manufacturing, and commercialization of the candidates.

“We are delighted to be working with Bristol Myers Squibb, a proven leader in oncology and immunology development, to identify and advance novel therapeutics for patients worldwide,” said Karen Akinsanya, Ph.D., Executive Vice President, Chief Biomedical Scientist and Head of Discovery R&D at Schrödinger. “We see tremendous potential in bringing together our drug discovery expertise with Bristol Myers Squibb’s depth of experience in development and commercialization.”

“This collaboration is an example of our continued commitment to developing potential clinical candidates that could lead to new therapies in these important disease areas,” said Rupert Vessey, M.A., B.M., B.Ch., F.R.C.P., D.Phil., Executive Vice President, Research & Early Development, Bristol Myers Squibb. “Our teams share the goal of transforming how new medicines are discovered and developed and may ultimately benefit patients.”

Terms of the Collaboration

Under the terms of the agreement, Bristol Myers Squibb will pay Schrödinger $55 million upfront, and Schrödinger will also be eligible to receive up to $2.7 billion in preclinical, development, regulatory and sales-based milestone payments. Additionally, Schrödinger is entitled to receive royalties on net sales of each product commercialized by Bristol Myers Squibb.

Schrödinger has agreed to grant Bristol Myers Squibb exclusive worldwide rights to develop and commercialize the development candidates generated by the collaboration.

For more information regarding the financial and other terms of the collaboration, please refer to the Current Report on Form 8-K which will be filed by Schrödinger with the U.S. Securities & Exchange Commission on November 23, 2020.

About Schrödinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages its software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrödinger has over 400 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com and follow us on LinkedIn and Twitter.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 including, but not limited to those regarding our expectations about the speed and capacity of our computational platform, our ability to discover novel therapeutics under the collaboration, the potential of our collaboration with Bristol Myers Squibb to develop new therapies, our ability to realize potential milestones, royalties or other payments under the collaboration and the risk that we may not realize the expected benefits of the collaboration. Statements including words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and statements in the future tense are forward-looking statements. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies, and prospects, which are based on the information currently available to us and on assumptions we have made. Actual results may differ materially from those described in these forward-looking statements and are subject to a variety of assumptions, uncertainties, risks and factors that are beyond our control, including our reliance upon third-party providers of cloud-based infrastructure to host our software solutions, our reliance on third party contract research organizations to assist in the discovery of development candidates, our reliance on Bristol Myers Squibb to perform its obligations to develop and commercialize any development candidates discovered by us under the collaboration, the uncertainties inherent in drug development and commercialization, uncertainties associated with the regulatory review of clinical trials and applications for marketing approvals, the potential impact of the COVID-19 pandemic on our operations or the operations of third parties we rely on, as well as the other risks and uncertainties identified under the caption “Risk Factors” and elsewhere in our Securities and Exchange Commission filings and reports, including the Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020, as well as future filings and reports by us. Any forward-looking statements contained in this press release speak only as of the date hereof. Except as required by law, we undertake no duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events, changes in expectations or otherwise.

Jaren Madden

Schrödinger, Inc.

[email protected]

617-286-6264

Adam Silverstein (media)

Ten Bridge Communications

[email protected]

917-697-9313

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Health Technology Other Technology Software General Health Pharmaceutical Biotechnology

MEDIA:

Logo
Logo
Posted on

MedMen x Viola Launch

MedMen x Viola Launch

LOS ANGELES–(BUSINESS WIRE)–
MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a leading cannabis retailer with operations across the United States, is pleased to announce the launch of Viola within all California locations. Founded in 2011 by NBA veteran and MedMen board member, Al Harrington, Viola is a premium cannabis company that focuses on increasing minority ownership, reinvesting in the community and creating opportunity through social equity. Launching with five potent strains; J1, Wedding Cake, Watermelon Zkittlez, Mother’s Milk and Mandarin OG – the offer spans the full spectrum from sativa to indica. The launch will also include Viola’s sativa Candy Haze pre-roll. See full descriptions, as promoted, below.

“We are thrilled to partner with Viola and for them to join our California product offer,” said MedMen interim CEO, Tom Lynch. “MedMen and Viola not only share a vision of inclusion and diversity within the industry and the communities we are privileged to serve, but also a commitment to the highest standards of quality and customer service.”

“We’re excited to bring our three most popular strains of Viola premium flower to MedMen stores across California,” said Al Harrington, CEO, Viola. “MedMen has been a true retail trailblazer within the cannabis industry and having our products featured in their stores will undoubtedly bring greater awareness to our brand and make it easier for residents to purchase Viola flower.”

Flower Descriptions:

J1: J1 is an uplifting super sativa nothing short of a clear headed buzz. Enticing trichome encrusted buds, accompanied by a tantalizing sweet aroma known to leave you feeling unstoppable!

Wedding Cake: This delectable strain offers euphoric effects with its peppery and earthy flavor profile. Novice smokers beware this indica dominant hybrid may knock your sweet tooth out.

Watermelon Zkittlez: Large dense nugs with a flavor profile reminiscent of your favorite fruit candy, Watermelon Zkittlez is the perfect midnight snack to fulfill your sweet tooth cravings. This scrumptious combo may ease you to an elevated state of relaxation.

Mandarin OG: Boasting a unique flavor profile of skunky, spicy, pine-like and orange flavors this powerhouse strain is known to combine a heavy body high with extreme mental relaxation. The perfect strain to unwind with after a long day.

Mother’s Milk: Luscious trichome encrusted dense nugs coupled with an earthy flavor profile may allow for a functional dreamy high. This sativa dominant hybrid is perfect for an evening out or a day relaxing in.

Sativa Pre-Roll Description:

Candy Haze: Bred from Candyland and Haze, Candy Haze stays true to its origins supplying uplifting and stimulating effects. The perfect day time smoke or mood boosting high to get your creative juices flowing.

To learn more about Viola, please visit Ember, MedMen’s digital editorial platform. Ember is high culture for all, providing a point of view on style, wellness, food, and travel through a cannabis filtered lens.

ABOUT MEDMEN:

MedMen is a cannabis retailer with flagship locations in California, Nevada, Illinois, Florida, and New York. MedMen offers a robust selection of high-quality products, including MedMen-owned brands [statemade], LuxLyte, and MedMen Red through its premium retail stores, proprietary delivery service, as well as curbside and in-store pick up. MedMen Buds, an industry-first loyalty program, provides exclusive access to promotions, product drops and content. MedMen believes that a world where cannabis is legal and regulated is safer, healthier and happier. Learn more about MedMen and The MedMen Foundation at www.medmen.com.

ABOUT VIOLA:

Founded in 2011 by NBA veteran Al Harrington, Viola is one of the nation’s leading producers and licensed wholesalers of premium quality cannabis products. The brand is named after and inspired by Al’s grandmother who suffers from glaucoma and diabetes, finding solace in cannabis remedies. Viola has integrated the latest cutting-edge technology with its own proprietary procedures designed for every stage of the cultivation, extraction and production process. The company is known for its wide variety of product offerings including a high-quality flower to premier butane extracts. For more information, please visit www.violabrands.com.

MEDMEN CONTACT:

Julian Labagh

Director of Consumer Communications

Email: [email protected]

www.medmen.com

IG: @shopmedmen

Tw: @medmen

VIOLA CONTACT:

Courtney Greenberg

Vice President, DKC Public Relations

Email: [email protected]

Pristina Alford

Senior Vice President, DKC Public Relations

Email: [email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Alternative Medicine Health Retail Tobacco Specialty

MEDIA:

Logo
Logo
Posted on

EnPro Announces Completion of Sale of STEMCO Air Springs Business

EnPro Announces Completion of Sale of STEMCO Air Springs Business

CHARLOTTE, N.C.–(BUSINESS WIRE)–
EnPro Industries, Inc. (NYSE: NPO), a leading technology company using materials science to push the boundaries of the semiconductor, life sciences, and other technology-enabled sectors, today announced that it has closed the previously announced sale of its STEMCO Air Springs business unit to an affiliate of private equity firm Turnspire Capital Partners for a purchase price of $39.5 million, subject to adjustment based on the amount of cash and working capital on the closing date, consisting of $25 million in cash at closing, a long-term promissory note with a face value of $7.5 million that will be stated at fair value, and the retention of accounts receivable of approximately $7 million. EnPro announced the agreement to sell the STEMCO Air Springs business on August 3, 2020.

The completion of this transaction is consistent with EnPro’s strategy to focus its portfolio on materials science-based businesses with leading technologies, compelling margins, strong cash flow, and high levels of recurring revenue that serve markets with favorable secular tailwinds. The company will continue to apply the EnPro Operating System to enable continuous improvement and allocate capital, organically and inorganically, to drive growth in businesses with these characteristics with the goal of maximizing long-term shareholder returns.

Fidus Securities, LLC served as exclusive financial advisor to EnPro, and Robinson Bradshaw served as legal counsel.

About EnPro

EnPro is a leading technology company using materials science to push the boundaries of the semiconductor, life sciences, and other technology-enabled sectors. For more information about EnPro, visit the company’s website at http://www.enproindustries.com.

About Turnspire Capital Partners

Turnspire Capital Partners invests in high-quality businesses that have reached strategic, financial or operational inflection points and stand to benefit from our hands-on, operationally focused approach. Turnspire’s investment philosophy is predicated on creating value through operational improvements rather than through financial leverage. Turnspire strives to make each of its companies best-in-class in their respective industry niche, and then to grow the businesses through organic initiatives or strategic acquisitions.

Forward-Looking Statements

Statements in this press release that express a belief, expectation or intention, as well as those that are not historical fact, are forward-looking statements under the Private Securities Litigation Reform Act of 1995. They involve a number of risks and uncertainties that may cause actual events and results to differ materially from such forward-looking statements. These risks and uncertainties include, but are not limited to: the extent of closing date adjustments to the purchase price; impacts from the COVID-19 pandemic and governmental responses to limit the further spread of COVID-19, including impacts on the company’s operations, and the operations and businesses of its customers and vendors, including whether the company’s operations and those of its customers and vendors will continue to be treated as “essential” operations under government orders restricting business activities or, even if so treated, whether site-specific health and safety concerns might otherwise require certain of the company’s operations to be halted for some period of time; uncertainty with respect to the duration and severity of these impacts from the COVID-19 pandemic, including impacts on the general economy and the markets served by the company’s customers; the extent to which the impacts from the COVID-19 pandemic could result in a reduction in demand for the company’s products and services, which could also result in asset impairment charges, including for goodwill; other economic conditions in the markets served by EnPro’s businesses and those of its customers, some of which are cyclical and experience periodic downturns and disruptions, such as the recent disruptions in the pricing of oil and gas; prices and availability of its raw materials; the impact of fluctuations in relevant foreign currency exchange rates; unanticipated delays or problems in introducing new products; announcements by competitors of new products, services or technological innovations; changes in pricing policies or the pricing policies of competitors; and the amount of any payments required to satisfy contingent liabilities related to discontinued operations and the discontinued operations of its predecessors, including liabilities for certain products, environmental matters, employee benefit obligations and other matters. EnPro’s filings with the Securities and Exchange Commission, including its most recent Form 10-K and Form 10-Q, describe these and other risks and uncertainties in more detail. EnPro does not undertake to update any forward-looking statements made in this press release to reflect any change in management’s expectations or any change in the assumptions or circumstances on which such statements are based.

Investor Contact:

Jerry L. Johnson

Senior Vice President – Strategy, Corporate Development and Investor Relations

Phone: 704-731-1527

Email: [email protected]

KEYWORDS: North Carolina United States North America

INDUSTRY KEYWORDS: Technology Chemicals/Plastics Semiconductor Manufacturing

MEDIA:

Logo
Logo
Posted on

Ares Management Completes Sale of Valet Living to GI Partners

Ares Management Completes Sale of Valet Living to GI Partners

Leading Provider of Amenity Services Experiences Significant Growth under Ares and Harvest Sponsorship

LOS ANGELES–(BUSINESS WIRE)–
Ares Management Corporation (NYSE: ARES) today announced that a fund managed by its Private Equity Group and Harvest Partners, LP have sold Valet Living, the largest nationally-recognized, full-service amenities provider to the multi-family housing industry, to GI Partners. Terms of the transaction were not disclosed.

Based in Tampa, Valet Living is the leading provider of value-added amenity services to the largest property owners, managers and residents nationwide. Serving more than 1.6 million apartment homes annually across 40 states, Valet Living provides the only full-service amenity solution offering with a scaled national footprint, including doorstep trash collection, turnkey apartment turnover and app-driven on-demand amenity services. Valet Living has consistently remained the #1 provider of amenity services in the United States, maintaining clear market leadership serving 30 times more homes than the nearest competitor.

“Since partnering with management to acquire Valet Living in 2015, we are proud to have supported the company during a period of strong double-digit top-line growth, which included both geographic expansion and the expansion of services from doorstep trash collection to turnkey rental unit turnover, front desk concierge, package management, housekeeping, pet walking, fitness classes and more,” said Matt Cwiertnia, Partner and Co-Head of the Ares Private Equity Group. “We would like to thank Harvest Partners for their partnership and we wish the Valet Living team continued success.”

“I want to thank the Ares Private Equity Team and Harvest for their support during the last five years as we expanded our solutions to over 1.6 million homes across the country,” said Shawn Handrahan, CEO of Valet Living. “We are excited for this next phase in the history of our great company and look forward to continuing to deliver exceptional living experiences to the residents of the communities we serve.”

“It has been a pleasure working with Shawn and his team over the past several years, during which time we entered several new geographies and added adjacent services,” said Michael DeFlorio, President of Harvest Partners. “This has been a great partnership with Ares and we expect continued success for Valet Living and GI Partners as they continue to grow the business.”

Harris Williams and Baird served as financial advisors to Valet Living. Kirkland & Ellis LLP served as the legal advisor to Valet Living, Ares and Harvest. Moelis & Company served as financial advisor to Ares and Harvest.

About Ares Management Corporation

Ares Management Corporation (NYSE: ARES) is a leading global alternative investment manager operating integrated groups across Credit, Private Equity, Real Estate and Strategic Initiatives. Ares Management’s investment groups collaborate to deliver innovative investment solutions and consistent, attractive investment returns for fund investors throughout market cycles. As of September 30, 2020, Ares Management’s global platform had approximately $179 billion of assets under management with more than 1,400 employees operating across North America, Europe and Asia Pacific. For more information, please visit www.aresmgmt.com.

About Harvest Partners

Founded in 1981, Harvest Partners, LP is a leading New York-based private equity investment firm pursuing management buyouts and recapitalizations of middle market companies in North America. Harvest focuses on acquiring profitable companies in the business services and consumer, healthcare, industrial services, and manufacturing and distribution sectors. This strategy leverages Harvest Partners’ nearly 40 years of experience in financing organic and acquisition-oriented growth companies. For more information, please visit www.harvestpartners.com.

About Valet Living

Valet Living is the largest nationally recognized full-service amenities provider to the multifamily housing industry, performing more than 340 million events annually across 1.6 million apartment homes and 40 states. Through its Valet Living Home app-enabled resident amenity service offering and its doorstep waste & recycling collection, turns, maintenance and pet solutions, Valet Living is also the only company in the multifamily industry to combine doorstep waste and recycling collection with both sustainability-related and premium home-related services. Valet Living has been setting the standard for residential living since 1995. For more information, please visit www.valetliving.com.

About GI Partners

Founded in 2001, GI Partners is a private investment firm based in San Francisco, California. The firm has raised over $23 billion in capital from leading institutional investors around the world to invest in private equity, real estate, and data infrastructure strategies. The private equity team invests primarily in companies in the Healthcare, IT Infrastructure, Services, and Software sectors. The real estate team invests across a broad range of platforms and strategies. The data infrastructure team invests primarily in hard asset infrastructure businesses underpinning the digital economy. For more information, please visit www.gipartners.com.

Media:

Mendel Communications

Bill Mendel, 212-397-1030

[email protected]

Ares Management Corporation

Priscila Roney, 212-808-1185

[email protected]

Investors:

Ares Management Corporation

Carl Drake, 800-340-6597

[email protected]

Harvest Partners, LP

Catherine Clifford, (212) 379-9102

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Finance Professional Services Residential Building & Real Estate Commercial Building & Real Estate Construction & Property

MEDIA:

Logo
Logo
Posted on

Verano Holdings Announces Upcoming Conference Participation

CHICAGO, Nov. 23, 2020 (GLOBE NEWSWIRE) — Verano Holdings, LLC (“Verano”), a leading multi-state cannabis owner, operator, and manager today announced that its executive team will participate in the following conferences in November and December 2020:

  • 2020 Cowen Boston Cannabis Conference (Virtual), November 30th– George Archos, Founder and CEO, will participate on a “U.S. MSOs: The Mid-West” panel moderated by Vivien Azer, Managing Director and Senior Research Analyst specializing in beverages, tobacco, and cannabis sectors at Cowen. Verano will also participate in one-on-one meetings.
  • 2020 Cantor Fitzgerald Virtual Cannabis MSO Summit, December 15th-16th– George Archos, Founder and CEO, will participate in a fireside chat hosted by Pablo Zuanic, Managing Director at Cantor. Register here.

About Verano:
Verano is a leading vertically-integrated multi-state cannabis operator in the U.S. An operator of licensed cannabis cultivation, processing and retail facilities, Verano is devoted to the ongoing development of communal wellness by providing responsible access to regulated cannabis products to the discerning high-end customer. Active in 12 U.S. states, with 17 active retail locations and approximately 440,000 square feet across its cultivation facilities, Verano has been profitable since it was founded. Verano produces a full suite of premium, artisanal cannabis products sold under its trusted portfolio of consumer brands: Encore™, Avexia™ and Verano™. Verano designs, builds and operates inimitable Zen Leaf™ branded dispensary environments that deliver a superior cannabis shopping experience in both medical and adult-use markets. Learn more at http://verano.holdings/

Contacts:



Investors



Verano Holdings

Aaron Miles
Head of Investor Relations
[email protected]



Media



Verano Holdings

David Spreckman
[email protected]

Financial Profiles

Debbie Douglas
[email protected]
949-375-3436



Posted on

Rugby Advances Exploration at El Zanjon Gold Project, Argentina

VANCOUVER, British Columbia, Nov. 23, 2020 (GLOBE NEWSWIRE) — Rugby Mining Limited (“Rugby” or the “Company”) (TSX-V: RUG) is pleased to report the commencement of a follow-up soil sampling program at the El Zanjon gold-silver project in Santa Cruz province, Argentina. The program will target gold-silver geochemical anomalies located on magnetic structures considered prospective for hosting high grade epithermal gold deposits (Please click here to view Figure 1).

The El Zanjon epithermal gold-silver project was acquired for its regional geologic and geophysical similarities to the Cerro Moro and Cerro Vanguardia gold systems. Negligible work had been done previously in the area. The project manager, Fernando Chacon, is the geologist who managed the exploration program for Extorre Gold Mines at the Cerro Moro discovery.

El Zanjon is located approximately 35 km south of AngloGold Ashanti’s multimillion-ounce Cerro Vanguardia gold mine and 50km southeast of E2 Metals recent greenfields discovery at the Mia prospect (Please click here to view Figure 2).

Mr. Bryce Roxburgh, CEO of Rugby commented, “The Mia discovery by E2 (18 m of 47 g/t gold and 208 g/t silver* in drilling) is the most recent indicator of the prospectivity of this region. Rugby’s project is an entirely greenfields play, yet each program vectors us closer to defining specific drill sites. We like this region a lot.”

El Zanjon is covered by a sedimentary veneer such that outcropping veins would be highly unlikely. Rugby has completed ground magnetics which delineated prominent structures. In addition, low level detection geochemical sampling was conducted over selected parts of this sedimentary cover. This work defined ten zones of anomalous gold-silver geochemistry ranging from 320 m to 2,800 m in length along these structures. A number of these anomalies have coincident lower pH readings suggesting an acidic environment which can indicate oxidizing sulfides at depth, an association common to other epithermal projects in the region.

Following recent Covid-19 related travel clearances our team has commenced a month-long follow-up soil sampling program. A total of 256 soil samples will be collected on 320 m spaced intervals (Please click here to view Figure 3).

*Source: E2 Metals website: https://e2metals.com.au/. This information and results associated to the E2 Metals discovery at the Mia Prospect has not been verified or confirmed by the Company and is only presented for information purposes only.

Paul Joyce, Rugby’s Chief Operating Officer, Director and a “qualified person” (“QP”) within the definition of that term in National Instrument 43-101, Standards of Disclosure for Mineral Projects, has verified the technical information that forms the basis for this news release.

About Rugby

Rugby is an exploration company conducting “discovery stage” exploration on targets in Colombia, Argentina, the Philippines and Australia. The Company controls a portfolio of gold projects in Colombia that do not require the Department of Forestry approval that stalled the Cobrasco copper project in Choco Province. These gold projects have considerable potential for gold, silver and copper discoveries.

The Company benefits from the experience of its directors and management, a team that has either been directly responsible for world-class mineral discoveries or have been part of the management teams responsible for such discoveries. Prior companies under their management included Exeter Resource Corporation and Extorre Gold Mines Limited, which held significant projects in South America. These companies were taken over by Goldcorp (Newmont) and Yamana respectively.

For additional information you are invited to visit the Rugby Mining Limited website at www.rugbymining.com.

Robert Grey, VP, Corporate Communications
Tel: 604.688.4941 Fax: 604.688.9532
Toll-free: 1.855.688.4941		 Suite 810, 789 West Pender St.
Vancouver, BC Canada V6C 1H2
[email protected]

CAUTIONARY STATEMENT

Certain of the statements made and information contained herein is “forward-looking information” within the meaning of the British Columbia, Alberta and Ontario Securities Acts. This includes statements concerning the Company’s plans at its projects including progress on obtaining approval for its exploration concession applications in Colombia, the expected timing of drilling and/or geophysics programs, prospectivity, high grade potential and potential for mineral discoveries, the style or occurrence of the mineralization and drilling costs which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information. In addition the Company holds certain of its projects under option agreements, which require expenditure and/ or drilling requirements in order to maintain its interest. Should the Company not be able to meet its obligations or renegotiate the agreements it will lose its rights under the option agreement. Forward-looking information is subject to a variety of risks and uncertainties which could cause actual events or results to differ from those reflected in the forward-looking information, including, without limitation, the effect on prices of major mineral commodities such as copper and gold by factors beyond the control of the Company; events which cannot be accurately predicted such as political and economic instability, terrorism, environmental factors and changes in government regulations and taxes; the shortage of personnel with the requisite knowledge and skills to design and execute exploration programs; difficulties in arranging contracts for drilling and other exploration services; the Company’s dependency on equity market financings to fund its exploration programs and maintain its mineral exploration properties in good standing; political risk that a government will change, interpret or enforce mineral tenure, environmental regulations, taxes or mineral royalties in a manner that could have an adverse effect on the Company’s assets or financial condition and impair its ability to advance its mineral exploration projects or raise further funds for exploration; risks associated with title to resource properties due to the difficulties of determining the validity of certain claims as well as the potential for problems arising from the interpretation of laws regarding ownership or exploration of mineral properties in the Philippines and Colombia and in the sometimes ambiguous conveyancing characteristic of many resource properties, currency risks associated with foreign operations, the timing of obtaining permits to conduct exploration activities, the ability to conclude agreements with local communities and other risks and uncertainties, the ongoing effects of the COVID 19 virus and including those described in each of the Company’s management discussion and analysis and those contained in its financial statements for the year ended February 29, 2020 filed with the Canadian Securities Administrators and available at www.sedar.com. In addition, forward-looking information is based on various assumptions including, without limitation, assumptions associated with exploration results and costs and the availability of materials and skilled labour. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking statements. Accordingly, readers are advised not to place undue reliance on forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information, whether as a result of new information, future events or otherwise.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE



Posted on

Metacrine to Participate in Upcoming Investor Conferences

SAN DIEGO, Nov. 23, 2020 (GLOBE NEWSWIRE) — Metacrine, Inc. (Nasdaq: MTCR), a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases, today announced that Preston Klassen, M.D., MHS, president and chief executive officer of Metacrine, will present at the following December investor conferences:

  • Piper Sandler 32nd Annual Virtual Healthcare Conference (fireside chat) being held December 1-3, 2020. Company presentations will be available for registered attendees on the Piper Sandler conference site from November 23 to December 3. Metacrine will participate in 1×1 meetings with investors during the conference on Wednesday, December 2, 2020.
  • Evercore ISI 3rd Annual HealthCONx (fireside chat) on Thursday, December 3, 2020 at 3:55 p.m. ET/12:55 p.m. PT. Metacrine will participate in 1×1 meetings with investors during the conference on Thursday, December 3, 2020.

Webcasts of the presentations will be available in the investor section of the company’s website at www.metacrine.com. The webcasts will be archived for 60 days following the presentations.

About
Metacrine

Metacrine, Inc. (Nasdaq: MTCR) is a clinical-stage biopharmaceutical company building a differentiated pipeline of therapies to treat liver and gastrointestinal (GI) diseases. The company’s most advanced programs, MET409 and MET642, target the farnesoid X receptor (FXR), which is central to modulating liver and GI diseases. Both MET409 and MET642 are currently being investigated in clinical trials as potential new treatments for non-alcoholic steatohepatitis (NASH).

Contact:

Chelcie Lister
THRUST Strategic Communications
910.777.3049
[email protected]



Posted on

DPW Holdings’ Coolisys® Power Electronics Business to Test ACECool™ EV Chargers Targeting National Fast-Food Franchise Networks

DPW Holdings’ Coolisys® Power Electronics Business to Test ACECool™ EV Chargers Targeting National Fast-Food Franchise Networks

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–
DPW Holdings, Inc. (NYSE American: DPW) a diversified holding company (“DPW,” or the “Company”), announced that its power electronics business, Coolisys Technologies Corp.® (“Coolisys®”), has established a program targeting both national and regional fast-food franchisees to install the ACECool™ electric vehicle (“EV”) chargers as a part of a revenue sharing program. The program initially will be funded from the Company’s recent capital raising activities. The program is expected to be launched in California, Nevada and Canada. While the Company is excited about Coolisys’ new franchise program, there is no assurance that the program will be successful.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201123005735/en/

The Company expects that the program will allow franchise owners and operators to install the ACECool™ EVchargers and share in the net revenue from advertising and network usage. This same program is anticipated to be a model for other strategic industry-focused and geo-focused networks. Coolisys expects to launch its program with a national fast-food network franchisee that forms a part of a network with over 1,000 locations. Coolisys expects to announce other network partners in the first quarter of 2021.

Global EV sales rose a dramatic 65% from 2017 to 2018, for a total of 2.1 million vehicles, with sales figures steady through 2019. The subsequent outbreak of the coronavirus pandemic, however, resulted in a 25% decline in EV purchases during the first quarter of 2020. Despite these setbacks, EV demand is again expected to rise according to a study by Bloomberg New Energy Finance, which sees improved batteries, more readily available charging infrastructure, new markets and price parity with internal combustion engine vehicles as the major growth drivers. The study estimates that EVs will comprise 10% of global passenger vehicle sales by 2025, rising to 28% in 2030 and 58% in 2040. In terms of expanding the current infrastructure to support EV deployment, McKinsey reported that by 2030 more the $30 billion will need to be spent on the rollout of EV chargers and, that by 2030, the US market for services to support the charging of EV fleets could be worth $15 billion.

Amos Kohn, President and CEO of Coolisys, said, “The opportunities for Coolisys in the burgeoning EV marketplace are anticipated to drive our sales growth over the next 60 months and beyond. We look forward to the potential changes coming from increased demand for EVs and the recent trends related to government support of the electrification of transport. I believe we are well positioned to leverage these opportunities as a 50+ year old company experienced and capable of creating innovative and highly-efficient power systems and solutions.”

For more information on DPW Holdings and its subsidiaries, the Company recommends that stockholders, investors and any other interested parties read the Company’s public filings and press releases available under the Investor Relations section at www.DPWHoldings.com or available at www.sec.gov.

About Coolisys Technologies Corp.

Coolisys and its portfolio companies and divisions are primarily engaged in the design and manufacture of innovative, feature-rich, and top-quality power products for mission-critical applications in the harshest environments and life-saving, life sustaining applications across diverse markets including defense/aerospace, medical/healthcare, industrial, telecommunications, and automotive. Coolisys’ headquarters are located at 1635 South Main Street, Milpitas, CA 95035; www.Coolisys.com.

About DPW Holdings, Inc.

DPW Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact. Through its wholly and majority-owned subsidiaries and strategic investments, the Company provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, telecommunications, medical, and textiles. In addition, the Company extends credit to select entrepreneurial businesses through a licensed lending subsidiary. DPW’s headquarters are located at 201 Shipyard Way, Suite E, Newport Beach, CA 92663; www.DPWHoldings.com.

Forward-Looking Statements

This press release contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company’s website at www.DPWHoldings.com.

[email protected] or 1-888-753-2235

KEYWORDS: California Nevada United States North America Canada

INDUSTRY KEYWORDS: Other Defense Professional Services Alternative Energy Alternative Vehicles/Fuels Energy Technology Automotive Defense Other Manufacturing Finance Other Technology Manufacturing

MEDIA:

Logo
Logo
Logo
Logo
Logo
Logo